Does USTEKINUMAB Cause Confusional state? 2,006 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,006 reports of Confusional state have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 2.4% of all adverse event reports for USTEKINUMAB.
2,006
Reports of Confusional state with USTEKINUMAB
2.4%
of all USTEKINUMAB reports
1,231
Deaths
1,555
Hospitalizations
How Dangerous Is Confusional state From USTEKINUMAB?
Of the 2,006 reports, 1,231 (61.4%) resulted in death, 1,555 (77.5%) required hospitalization, and 1,383 (68.9%) were considered life-threatening.
Is Confusional state Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 2,006 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Confusional state?
METHOTREXATE (4,962)
ACETAMINOPHEN (4,630)
OXYCODONE (4,599)
PREDNISONE (4,441)
ADALIMUMAB (4,399)
RITUXIMAB (4,020)
TOCILIZUMAB (3,949)
ABATACEPT (3,879)
LEFLUNOMIDE (3,795)
PIMAVANSERIN (3,779)
Which USTEKINUMAB Alternatives Have Lower Confusional state Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE